High FGF23 Levels Failed to Predict Cardiac Hypertrophy in Animal Models of Hyperphosphatemia and Chronic Renal Failure

Increased fibroblast growth factor 23 (FGF23) levels are an independent predictor for adverse cardiac events suggesting a role as a link that drives cardiomyopathic changes in cardiorenal syndrome. The search for the underlying mechanism driving this interaction has led to the hypothesis that FGF23...

Descripción completa

Detalles Bibliográficos
Autores principales: Moench, Ian, Aravindhan, Karpagam, Kuziw, Joanne, Schnackenberg, Christine G, Willette, Robert N, Toomey, John R, Gatto, Gregory J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275024/
https://www.ncbi.nlm.nih.gov/pubmed/34268460
http://dx.doi.org/10.1210/jendso/bvab066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275024/
https://www.ncbi.nlm.nih.gov/pubmed/34268460
http://dx.doi.org/10.1210/jendso/bvab066

Ejemplares similares